Viewing Study NCT02501304


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-01-11 @ 6:10 PM
Study NCT ID: NCT02501304
Status: COMPLETED
Last Update Posted: 2016-11-04
First Post: 2015-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Feasibility Study of the ReVENT Sleep Apnea System
Sponsor: Revent Medical International B.V.
Organization:

Study Overview

Official Title: Feasibility Study of the ReVENT Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)
Status: COMPLETED
Status Verified Date: 2016-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: REV-001
Brief Summary: This is a prospective, multi-center, single arm, feasibility study to evaluate the safety and effectiveness of the ReVENT Sleep Apnea System for the treatment of Obstructive Sleep Apnea.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: